Form D · Other Health Care
ArthroMeda, Inc.
Lowell, MA · CIK 0001566819
Offering snapshot reported Oct 13, 2026 · SEC filing
- Reported sold
- $8.75M Offering amount: $11.1M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 14, 2026 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$8,599,583 → $8,749,582
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2026 | Amendment | $8,749,582 | $149,999vs Aug 20, 2026 | 12 | SEC filing |
| Aug 20, 2026 | Initial | $8,599,583 | No comparison | 12 | SEC filing |
| Jul 15, 2025 | Amendment | $3,237,868 | $800,000vs Feb 4, 2025 | 12 | SEC filing |
| Feb 4, 2025 | Amendment | $2,437,868 | $150,000vs May 6, 2024 | 12 | SEC filing |
| May 6, 2024 | Amendment | $2,287,868 | $374,400vs Sep 3, 2021 | 12 | SEC filing |
| Sep 3, 2021 | Initial | $1,913,468 | No comparison | Not reported | SEC filing |
| Jan 6, 2020 | Amendment | $1,794,660 | $1,000,000vs Feb 28, 2019 | 11 | SEC filing |
| Feb 28, 2019 | Initial | $794,660 | No comparison | 10 | SEC filing |
| Jun 29, 2018 | Initial | $1,200,000 | No comparison | 10 | SEC filing |
| Jun 7, 2017 | Initial | $1,499,994 | No comparison | 10 | SEC filing |
| Mar 24, 2016 | Initial | $1,924,094 | No comparison | 4 | SEC filing |
| Jan 6, 2014 | Initial | $1,641,222 | No comparison | 12 | SEC filing |
| Jan 11, 2013 | Initial | $695,002 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $140K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-594943
Amounts include conversion of outstanding indebtedness and warrants issued in connection with the offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Brookline Capital Markets | 44656 | Arcadia Securities, LLC · CRD 44656 |
Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mehran Aghazadeh | Director |
| Pj Anand | Director, Executive |
| Edgar D. Jannotta Jr. | Director |
| Edgar D. Jannotta, Jr. | Director |
| Hans Joachim Simon | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
172 Middle Street Suite 207
Lowell, MA, 01852
Lowell, MA, 01852